Pharma Focus Asia

Previous Issue - Issue 47

This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.

ahhm-current-issue

Issue 47 | 2022

  • Foreword
  • Strategy
  • Research & Development
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Expert Talk
  • Advertorials
  • Go to Digital Magazine

Issue 47

PREVIOUS ISSUE

Foreword

Future of Pharmacovigilance

Emerging role of AI

Healthcare data plays a key role in improving quality of life as accurate data can help doctors patients and other stakeholders involved take the right decisions

Strategy

STRATEGIC INSTINCTS

Four Strategic Instincts Separate Great Strategists from the Others.

You are probably alltoofamiliar with the rigmarole of strategic planning situational analyses and spreadsheets slide decks and strategy reviews

PHAMACEUTICAL PROMOTION MATERIAL

GLOBAL LAWS OVERVIEW

One of the most important tasks of any regulatory body is to ensure that pharmaceutical products are developed in accordance with the localregional regulatory requirements

Research & Development

STEM CELLS FOR CANCER THERAPY

Despite several advances research cancer remains one of the deadliest diseases across the world The type of treatment provided depends upon the type and progression of cancer

BENCHMARKING PHARMACEUTICAL QUALITY CONTROL LABS

Holistic assessment of operational excellence in pharmaceutical companies

The importance of Operational Excellence OPEX to drive business performance and sustainable growth has been recognised across industries Mitchell

ENVIRONMENTAL AND SUSTAINABILITY REQUIREMENTS IN DRUG PROCUREMENT

To preserve a healthy environment and human wellbeing there is a recognised need to move away from overconsumption waste and ecological harm

Drug Development in the Technology Era

Legal Considerations for Computer-Assisted Drug Design

With the cost of developing a new pharmaceutical product currently hovering around US m to USm and taking approximately ten years from product inception to approval the pharmaceutical industry is understandably keen to identify ways to reduce these metrics

Clinical Trials

Current Trends in Pharmacogenomics that will shape Clinical Trials

The complete human genome was published in March heralding a new era in pharmacogenomics advancing genome analysis and unlocking value additions in precision medicine

Manufacturing

NEXTGENERATION CELL CULTURE MEDIA AND FEEDS SYSTEMS

A multi-faceted approach for optimising monoclonal antibody manufacturing productivity

Since the s monoclonal antibody mAb therapies have been a growing part of modern medicines toolbox of biopharmaceuticals with no sign of this progress slowing down

Ensuring Efficiency in Packaging Process should be a top Priority for Pharma Packaging Companies

The pharmaceutical industry is one where decades of innovation lead to one new product like a drug or vaccine

THE USE OF CRYSTAL ENGINEERING TO EFFECTIVELY TARGET LUNG INFECTIONS

Lung infections especially lower respiratory tract infections are one of the leading causes of transmissible deaths worldwide according the world health organisation

Information Technology

A DIGITALISED FUTURE FOR PHARMACOVIGILANCE

Pharmacovigilance PV is increasingly taking its toll on life science organisations

Expert Talk

Innovative Biotech Ecosystem in Singapore and Asia

Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster

Advertorials

Developing a Robust Contamination Control Strategy

Ecolab’s approach

As most readers will be aware Annex of EudraLex Volume GMPs is being updated The process has been somewhat protracted with multiple versions being reviewed updated and discardedAs most readers will be aware Annex of EudraLex Volume GMPs is being updated The process has been somewhat protracted with multiple versions being reviewed updated and d...

SGS QUALITY-DRIVEN SOLUTIONS

Discovery to commercialisation

Our bespoke testing and clinical service offering which covers full clinical development from Phase I firstinhuman trials to Phase II and Phase III studies in patients provides reliable and accurate results that ensure the safety of your products and protect patient health

EHS & ESG DIGITALISATION IN PHARMACEUTICAL INDUSTRIES

Dr. Reddy’s partnered with Benchmark ESG | Gensuite to digitalise and enhance their safety culture.

In Pharma as in other industries were in an age where the needs and obligations of companies are evolving by the second from accelerated product cycles to keeping up with investor and government demands for Environmental Social Governance ESG metrics

GMP Biotech Fast-Track Manufacturing Facilities

Supported by new modular solutions

Developing and delivering an innovative modular solution for biopharmaceutical manufacturing requires knowing both the cleanroom technology and the process design of these facilities

magazine-slider-image